T he vascular system of vertebrates consists of a stereotyped and highly branched network of arteries, veins, and capillaries. This network extends into every tissue of the body and is tailored to its local physiological function. [1] [2] [3] The development of vascular networks requires 2 successive processes, vasculogenesis and angiogenesis. 1, 2 During vasculogenesis, mesoderm-derived hemangioblasts differentiate in situ into endothelial cells (ECs), which coalesce at the midline to form a lumenized vascular plexus. 1, 2 This primary network subsequently expands through angiogenesis, which is characterized by the growth of new blood vessels from preexisting ones. 1, 2 Numerous ligands and their receptors have been identified to exert positive or negative regulation on angiogenesis, including vascular endothelial growth factor (VEGF)/ VEGF receptors, angiopoietin/Tie and notch/␦-like 4, [3] [4] [5] [6] [7] [8] and their downstream signaling pathways have also been partially elucidated. [3] [4] [5] [6] [7] For example, VEGF-induced angiogenesis is mainly attributable to the activation of both Mitogen-activated protein kinase/extracellular signalregulated kinase (ERK)1/2 cascade and AKT/protein kinase B pathway. 9 Angiopoietin1/Tie2-induced EC migration during angiogenesis is largely mediated by the activation of phosphoinositide 3-kinase signaling pathway. 8 There is increasing evidence that guidance of vessels and nerves during development share common underlying mechanisms. [2] [3] [4] [5] [6] 10, 11 Some axon guidance molecules, such as ephrins, netrins, and slits, also influence angiogenic sprouting. 3, 6, 7, 10, 11 Recent studies have shown that Ca 2ϩ -permeable transient receptor potential type C channels (TRPCs) 12 are downstream effectors of the axon guidance molecules netrin-1, brain-derived neurotrophic factor and myelinassociated glycoprotein, and are required for axon guidance triggered by these cues. [13] [14] [15] The TRPC family is composed of 7 members in mammals (TRPC1 to -7). 12 In the vascular system, TRPCs are expressed in ECs 16 and required for VEGF-induced elevation of intracellular Ca 2ϩ and regulation of vascular functions, such as vascular tone and permeability. [17] [18] [19] However, the role of TRPCs in vascular development remains largely unknown. The goal of this study is to investigate whether TRPCs are important for angiogenesis in vivo.
The zebrafish has emerged as a powerful vertebrate model system for in vivo study of vascular development. 20 Transgenic lines with vascular ECs expressing fluorescent proteins allow imaging of blood vessel growth in live embryos. 21, 22 Moreover, a range of reverse genetic methods, including the antisense morpholino oligonucleotide (MO)-based knockdown approach, 23, 24 have been developed for manipulating gene expression and function in zebrafish. 25 Recently, zebrafish trpc1 was identified. It is highly homologous to mammalian trpc1 and ubiquitously expressed postfertilization until 24 hours. 26 In the present study, we examined the role of TRPC1 in angiogenesis in vivo during zebrafish development. We found that knockdown of zebrafish trpc1 by MOs led to severe defects in the angiogenic sprouting of intersegmental vessels (ISVs). Cell transplantation experiments indicated that trpc1 functioned autonomously in ECs. In vivo time-lapse imaging of cellular behaviors showed that the angiogenic defect caused by trpc1 deficiency was associated with markedly impaired filopodia extension, migration, and proliferation of ISV tip cells. Furthermore, genetic and biochemical evidences suggest that Trpc1 acts downstream to Vascular endothelial growth factor A (Vegf-a) in controlling angiogenesis. Taken together, these results demonstrate for the first time that Trpc1 is essential for angiogenesis in vivo. 
Methods
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Results
Trpc1 Knockdown Causes Severe Angiogenesis Defects In Vivo
To examine the expression of zebrafish trpc1, we first performed whole-mount in situ hybridization at embryos of 1 day postfertilization (dpf) and found that trpc1 was ubiquitously expressed (Online Figure I ), consistent with a previous report. 26 Fluorescence-activated To investigate the role of TRPC1 in vascular development, the MO knockdown approach was used to downregulate zebrafish trpc1 by embryonic injection of trpc1-MO1, which was designed to target the start codon region (from Ϫ22 to ϩ3 bp) of zebrafish trpc1 mRNA (Online Figure III) . To validate the knockdown efficiency, we coinjected a trpc1-EGFP reporter (see Online Data Supplement) and found that the reporter expression was effectively suppressed by trpc1-MO1 but not by a control MO (Online Figure IV, A through D). In addition, trpc1-MO1 did not prevent the trpc4-EGFP reporter expression (Online Figure IV , E and F), indicating the specificity of trpc1-MO1.
Next, we injected control MO or trpc1-MO1 into 1-or 2-cell stage embryos of Tg(fli1:EGFP) y1 zebrafish and examined trunk vascular development at different stages using in vivo confocal imaging. We found that control MO-injected embryos developed normally ( Figure 1A) , whereas trpc1-MO1-injected embryos (trpc1 morphants) displayed mildly upward-curved tails and small eyes (Figure 1B) . At 24 hours postfertilization (hpf), ISVs, which are formed via angiogenesis, 28 grew dorsally after emerging from the dorsa aorta (DA) in control embryos ( Figure  1C ). However, ISVs were largely absent in trpc1 morphants ( Figure 1D ). At 30 hpf, ISVs in control embryos navigated to the dorsal roof of the neural tube, with their endothelial tip cells splitting into rostral and caudal branches to form the dorsal longitudinal anastomotic vessel (DLAV) via fusion with branches from adjacent segments ( Figure 1E ). In contrast, ISVs in trpc1 morphants grew only halfway through their ventral trajectory and stalled at the boundary between the notochord and neural Figure 1J ). In addition, the DA, which is formed via vasculogenesis, 28 poorly lumenized and did not fully separate with the posterior cardinal vein (PCV) in trpc1 morphants at 24 hpf ( Figure 1D ). By 30 hpf, trpc1 morphants displayed a reduced lumen size in DAs ( Figure 1F and 1K) but not in PCVs ( Figure 1F and 1L).
To validate the specificity of trpc1-MO1, we designed trpc1-MO2, targeting at a different region (from Ϫ53 to Ϫ29 bp) on the trpc1 mRNA (Online Figure III) . Trpc1-MO2 morphants displayed impaired ISV formation and DA lumenization ( Figure 1G ) similar to those observed in trpc1-MO1 morphants. Furthermore, we performed rescue experiments by coinjection of a MO1-resistant form of full-length zebrafish trpc1 mRNA (see Online Data Supplement), and found that the defects caused by trpc1-MO1 were significantly alleviated ( Figure 1H and 1I): both the average length (65.0Ϯ1.6 m) of ISVs ( Figure 1J ) and the average lumen size (19.2Ϯ1.6 m) of DAs ( Figure 1K ) were partially restored. Taken together, these results indicate that trpc1 is required for in vivo vascular development in zebrafish, especially for ISV angiogenesis.
Trpc1 Knockdown Does Not Affect Arterial-Venous Identity
To assess the effects of trpc1 knockdown on arterial-venous identity, we examined the expression of typical artery-and vein-specific markers in 27-hpf embryos by whole-mount in situ hybridization. Both ephrin-B2a and notch3, which are selectively expressed in arteries, 29, 30 were expressed in DA regions with comparable levels between control embryos and trpc1 morphants (Figure 2A through 2D ). The more patchy and irregular ephrin-B2a and notch3 expression in the morphants may be related to the reduced lumen size of DAs. Consistently, another arterial marker hRT 31 was expressed normally in trpc1 morphants ( Figure 2E and 2F) . Further examination of the expression of the venous markers flt4 32 and EphB4 29 in PCV regions showed that these genes were also expressed normally in trpc1 morphants ( Figure 2G through 2J). Thus, trpc1 appeared to be dispensable for the development of arterial-venous identity.
Trpc1 Requirement for ISV Formation Is Cell-Autonomous
We next examined whether the requirement of trpc1 in ISV angiogenesis is cell-autonomous by cell transplantation experiments. As shown above ( Figure 1C and 1D ), ISVs were absent in trpc1 morphants but had sprouted extensively from DAs by 24 hpf in control embryos. We thus examined at 24 hpf whether cells derived from WT embryos formed ISV Figure  3D through 3F and 3J) . Together, these results indicate that trpc1 acts in ISV formation largely in a cell-autonomous manner.
Trpc1 Knockdown Impairs ISV Tip Cell Behaviors
Endothelial tip cells extend dynamic filopodia to sense anti-and proangiogenic cues in their surrounding and direct the outgrow of capillaries. 28, 33, 34 To study cellular mechanisms underlying the angiogenic defect of ISVs caused by trpc1 knockdown, we first performed in vivo time-lapse imaging of ISV tip cell filopodia in Tg(fli1:EGFP) y1 embryos. We compared the filopodia dynamics of ISV tip cells between trpc1 morphants and WT embryos by assaying the extent of filopodia extension and retraction over Ϸ100 minutes, as indicated by the total area covered by the extended and retracted filopodia, respectively ("red" and "green" areas shown in the boxed region of Figure 4A and 4B). We found significant reduction in the filopodia extension but not retraction in trpc1 morphants ( Figure 4C through 4E ). This is in agreement with the ISV defect in trpc1 morphants. Next, we examined the behavior of ISV tip cell nuclei using in vivo time-lapse imaging of Tg(fli1:nEGFP) y7 embryos, in which EGFP accumulates in the nucleus of ECs. In WT embryos, ISV tip cells emerged from the DA before 20 hpf, and then migrated dorsally ( Figure 5A ). After arrival at the level of the horizontal myoseptum, most tip cells underwent a single cell division (93.8Ϯ4.4%, Figure 5A and 5C) and then continued to migrate along a stereotyped intersomitic pathway to reach the dorsal roof of the neural tube at around 28 hpf, with an average speed of 0.14Ϯ0.01 m/min ( Figure 5D ). In contrast, ISV tip cells in trpc1 morphants exited from the DA later than 24 hpf and only less than half of them underwent cell division (24.4Ϯ7.3%, Figure 5B and 5C). Furthermore, these cells migrated at a speed of 0.07Ϯ0.01 m/min, which was only half of that in WT embryos ( Figure 5D ).
These results indicate that trpc1 expression is required for filopodia extension, migration, and proliferation of ISV tip cells, and that the angiogenic defect of ISVs caused by trpc1 knockdown may be attributed to the impairment of these cellular processes.
Trpc1 Is Downstream to Vegf-a in Controlling Angiogenesis In Vivo
The angiogenic defect of ISVs in trpc1 morphants suggests that ISV tip cells may fail to navigate in response to proangiogenic cues in the absence of Trpc1, reminiscent of the ISV defect in embryos with impaired vegf signaling pathway. [35] [36] [37] In particular, the ISV defect of trpc1 morphants well recapitulated the ISV defect in vegf-a morphants (Online Figure V, A, B , and D; also see Nasevicius et al 38 ) . It is appealing to hypothesize that Trpc1 may share some common signaling pathways with Vegf-a. To explore whether Trpc1 is downstream or upstream to Vegf-a in zebrafish embryos, we overexpressed vegf 165 , 1 of the 2 dominant splice isoforms of zebrafish vegf-a, by injecting vegf 165 DNA into 1-or 2-cell stage embryos. 39 The overexpression of vegf 165 significantly induced ectopic growth of subintestinal veins (SIVs) at 3 dpf (Online Figure VI, A, B, D , and E), consistent with previous reports. 36 Figure VII) . Furthermore, we found that injecting 4 ng of trpc1-MO1 had no obvious effect on normal SIV formation ( Figure 6A , 6B, 6E, and 6F). However, both the branch point number and length of vegf 165 overexpression-induced ectopic SIVs were markedly decreased by coinjection with 4 ng of trpc1-MO1 ( Figure 6C through 6F) . Collectively, these results suggest that Trpc1 is downstream to Vegf-a in controlling angiogenesis.
Further study showed that Trpc1 and Vegf-a exerted a strong synergistic effect on ISV formation. A series of dosage of trpc1-MO1 and vegf-a-MO were first tested. We found that injection of either 0.5 ng of vegf-a-MO ( Figure 7B ) or 4 ng of trpc1-MO1 ( Figure 7C ) resulted in only a slight impairment of ISV formation in a small fraction of embryos, with most embryos exhibiting normal ISVs ( Figure 7E ). However, coinjection of 0.5 ng of vegf-a-MO and 4 ng of trpc1-MO1 led to severe defects in ISV formation in most embryos ( Figure 7D and 7E) , indicating a synergistic effect of Trpc1 and Vegf-a in controlling angiogenesis.
Trpc1 Is Required for ERK Activation
The mitogen-activated protein kinase/ERK1/2 cascade, which can be activated by VEGF, plays an important role in angiogenesis. 9 In zebrafish embryos, a previous report has shown that phosphorylated (p)-ERK is expressed in early arterial progenitors. 41 To explore signaling pathways mediating the Trpc1 effect on angiogenesis, we examined whether Trpc1 is required for ERK phosphorylation. We first found that p-ERK was expressed in ISVs at 30-hpf embryos ( Figure 8A ; Online Figure VIII) . Further analysis showed that knockdown of trpc1 by trpc1-MO1 markedly decreased the level of p-ERK expression, revealed by both immunohistochemistry ( Figure 8A and 8B) and Western blotting ( Figure 8C and 8D) . Moreover, the elevation of p-ERK induced by vegf 165 mRNA injection was also significantly suppressed by coinjection with trpc1-MO1 ( Figure 8C and 8D) .
Next, we found that inhibition of MEK, an upstream kinase of ERK, with the specific inhibitor PD98059, 42 which significantly reduced the level of p-ERK expression in ISVs (Online Figure IX) , mimicked the angiogenic defects caused by trpc1 knockdown, as indicated by the significant reduction in the ISV length (54.1Ϯ1.7 versus 101.6Ϯ1.4 m in the control, PϽ0.0001; Figure 8E and 8F) and in the number of ECs per ISV (1.8Ϯ0.1 versus 3.3Ϯ0.1 in the control, PϽ0.0001; Figure 8G and 8H). Taken together, these findings indicate that Trpc1 is required for ERK phosphorylation, and suggest that disruption of ERK signaling by trpc1 knockdown may account for Trpc1 deficiency-induced angiogenic defects.
Discussion
The present study provides the first line of in vivo evidence that Trpc1 is essential for angiogenesis. With use of zebrafish as an intact animal model, the experiments of loss-offunction, cell transplantation, time-lapse imaging, genetic interaction, immunohistochemistry and Western blotting collectively revealed that Trpc1 cell-autonomously affects angiogenesis in vivo possibly via regulating the filopodia extension, migration and division of endothelial tip cells, and functions downstream to Vegf-a. 
Roles of TRPCs in Vascular Development
Calcium dynamics in ECs is critical for pro-and/or antiangiogenic factor-induced events associated with angiogenesis. 16, 43 For example, inhibition of ligand-evoked Ca 2ϩ influx by carboxyamidotriazole impairs EC adhesion, motility and proliferation induced by fibroblast growth factor 2 in vitro and angiogenesis in the chicken chorioallantoic membrane in vivo. 44 ECs express a variety of Ca 2ϩ -permeable ion channels in the plasma membrane, which provide diverse routes for EC calcium entry. 45 However, it is still largely unknown what channels are responsible for the calcium influx of ECs. 45 TRPCs are kinds of Ca 2ϩ -permeable ion channels and expressed in ECs of various species, 16, 45 including zebrafish. 26 Diverse stimuli, such as proangiogenic factors, vasoactive agents, and oxidative stress, can activate TRPCs, leading to calcium influx in ECs and regulation of vascular functions. 16 -18 Recently, 2 in vitro studies showed that inhibition of TRPC6 suppressed VEGF-induced increase in cytosolic calcium, proliferation and migration of cultured human ECs, 46, 47 suggesting the involvement of TRPC6 in angiogenesis in vitro. In the present study, we used zebrafish as an intact animal model and found that trpc1 knockdown caused severe angiogenic defects in ISVs, indicating that Trpc1 is required for angiogenesis in vivo. It extends our knowledge about TRPC functions to vascular development in vivo. Considering the fact that TRPCs are required for axon guidance, [13] [14] [15] our study provides another parallel between vascular and neural development.
Effects of TRPCs on Endothelial Tip Cells
During vascular development, endothelial tip cells, which locate at the leading edge of vascular plexus, dynamically extend and retract their filopodia to sense vascular guid- ance cues and steer blood vessel outgrowth. 28, 33, 34 The impairment of tip cell functions certainly causes abnormal angiogenesis. 4, 6, 28, 33, 34 Our in vivo time-lapse imaging revealed that trpc1 deficiency reduced the filopodia extension, migration, and division of ISV tip cells. We believe that the angiogenic defect in trpc1 morphants is largely caused by the impairment of those behaviors of ISV tip cells. Consistently, it has been found that TRPC6 was involved in VEGF-induced sprouting and migration of cultured ECs 46, 47 and TRPC1 could regulate proliferation in other cell types. 48 For example, deficiency in TRPC1 led to attenuation of pulmonary artery smooth muscle cell proliferation. 48 As VEGF-activated signaling of MEK-ERK cascade is critical for the proliferation and migration of ECs, 9 disruption of ERK signaling by trpc1 knockdown might be responsible for the defects in the behavior of ISV tip cells.
Cell-Autonomous Effects of trpc1 on ISV Development
The transplantation analysis indicates an EC-autonomous role of trpc1 in controlling ISV formation, consistent with the expression of trpc1 in ECs. This is further supported by the evidence that Trpc1 is downstream to Vegf-a because Vegf-a/Vegf receptor signaling responsible for ISV development functions inside ECs of ISVs. 36, 38 As trpc1 is ubiquitously expressed in zebrafish, 26 we cannot exclude the possibility that Trpc1 expressed in surrounding cells contributes non-cell-autonomously to ISV formation. In our study, the ratio of the donor contribution to host ISV formation in WT EGFP ϾMO chimeras (21.1%) was smaller than that in WT EGFP ϾWT chimeras (36.7%) ( Figure 3J ), implying a possible role of non-cell-autonomous effects of trpc1 on ISV formation. A previous study reported that loss of TRPC4 resulted in an impaired secretion of thrombospondin-1, which is an inhibitor of angiogenesis, from renal cell carcinoma and thus facilitated angiogenesis in the tumor environment. 49 Taken together, we propose that TRPCs regulate angiogenesis possibly via 2 nonexclusive mechanisms. First, TRPCs may function inside ECs to directly modulate their responses to anti-and/or proangiogenic factors. Second, TRPCs may regulate the production and/or secretion of those factors in cells surrounding blood vessels and indirectly regulate vessel growth. Nevertheless, as donor cells derived from trpc1 morphants did not make any contribution to the formation of ISVs in MO EGFP ϾWT chimeras ( Figure 3D through 3F and 3J), it indicates that Trpc1 expressed in ECs plays a dominant role in ISV growth.
TRPCs and VEGF Signaling in the Vascular System
In our study, 2 lines of evidence indicate that Trpc1 is downstream to Vegf-a in controlling angiogenesis in vivo. First, trpc1 knockdown prevented Vegf-a-induced ectopic angiogenesis of SIVs. Second, trpc1 knockdown suppressed Vegf-a overexpression-induced increase in the level of p-ERK expression. Consistently, previous studies in cultured human ECs showed that TRPC1, TRPC3, and TRPC6 are required for VEGF-induced cytosolic calcium increase. 19, 46, 50 Moreover, zebrafish embryos lacking other components of Vegf signaling pathway showed similar angiogenic defects. 35, 37, 38 It is possible that the angiogenic defect caused by trpc1 knockdown may be caused by the disruption of Vegfa-triggered intracellular calcium increase and subsequent blockade of ERK signaling. Interestingly, overexpression of zebrafish trpc1 mRNA could not prevent the ISV defect in vegf-a morphants (Online Figure V, B through D) , implying that the expression of Trpc1 is necessary but not sufficient for Vegf-a-induced angiogenesis. This is consistent with the notion that binding by its extracellular or intracellular ligands is required for TRPC activation. [12] [13] [14] [15] [16] In vegf-a morphants, it is possible that, because of Trpc1 ligand deficiency caused by vegf-a knockdown, overexpressed Trpc1 could not be activated, resulting in inability of Trpc1 overexpression in suppressing the ISV defect in vegf-a morphants.
In conclusion, the present study took use of an intact animal model to illustrate that Ca 2ϩ -permeable ion channels participate in angiogenesis in vivo, and reveal a novel role of TRPC1 in cardiovascular biology. Notably, our finding supports that TRPC1 may be a potential target for suppressing pathological angiogenesis, offering important therapeutic implications for tumor therapy. 
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